# WuXi AppTec Lab Testing Division: Drug Development Laboratory Testing

Generated by Yoast SEO v27.3, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Contact Us](https://labtesting.wuxiapptec.com/contact-us/): 						
- [Digital Learning](https://labtesting.wuxiapptec.com/digital-learning/)
- [Meet Our Experts](https://labtesting.wuxiapptec.com/meet-our-experts/)
- [Vaccine Development](https://labtesting.wuxiapptec.com/safety-assessment-services/vaccine-development/)
- [Trade Articles](https://labtesting.wuxiapptec.com/trade-articles/)

## Posts
- [ADCs and Ocular Toxicity: Mechanisms and Management](https://labtesting.wuxiapptec.com/2026/04/01/adcs-and-ocular-toxicity-mechanisms-and-management/): The mechanisms of ocular toxicity in ADCs and how to manage them\.   
- [Six Ways Developers Can Address Ocular Safety in ADCs](https://labtesting.wuxiapptec.com/2026/04/01/six-ways-developers-can-address-ocular-safety-in-adcs/): ADCs pose significant ocular safety challenges to researchers which can cause costly delays\. 
- [WuXi AppTec Launches Research Book Decoding DMPK Frontiers for Novel Therapeutics](https://labtesting.wuxiapptec.com/2025/08/19/wuxi-apptec-launches-research-book-decoding-dmpk-frontiers-for-novel-therapeutics/): The pharmaceutical industry is constantly evolving\. New tools and methods are accelerating the pace of progress, facilitating efficient development of much\-needed therapies\. But the rise of novel drug modalities has presented challenges and opportunities and is driving continuous innovation and progress in Drug Metabolism and Pharmacokinetics \(DMPK\) research\.
- [Strategic Insights for Advancing PROTACs Toward IND Submission](https://labtesting.wuxiapptec.com/2025/12/05/strategic-insights-for-advancing-protacs-toward-ind-submission/): Peptides present unique safety challenges, with distinct immunogenic potential and tissue distribution patterns that standard testing approaches often miss\. What safety assessments cover these gaps?  
Complete safety data packages enable confident IND submissions and help researchers avoid safety failures in later development stages
- [6 Strategies to Overcome PROTACs' Developmental Challenges](https://labtesting.wuxiapptec.com/2025/05/01/6-strategies-to-overcome-protacs-developmental-challenges/): Proteolysis\-targeting chimeras \(PROTACs\) are some of the most eagerly discussed therapies in the world due to their potential to treat conditions previously thought undruggable\. Their ability to degrade rather than inhibit proteins means they can better treat complex diseases such as cancers and neurodegeneration, giving them advantages over traditional small molecule drugs\. 

## Events
- [Event Title](https://labtesting.wuxiapptec.com/event/event-title/)

## Type
- [section](https://labtesting.wuxiapptec.com/layout_type/section/)
- [module](https://labtesting.wuxiapptec.com/layout_type/module/)
- [layout](https://labtesting.wuxiapptec.com/layout_type/layout/)
- [row](https://labtesting.wuxiapptec.com/layout_type/row/)

## Module Width
- [regular](https://labtesting.wuxiapptec.com/module_width/regular/)
- [fullwidth](https://labtesting.wuxiapptec.com/module_width/fullwidth/)

## Scope
- [not\_global](https://labtesting.wuxiapptec.com/scope/not_global/)
- [global](https://labtesting.wuxiapptec.com/scope/global/)

## Optional
- [Sitemap index](https://labtesting.wuxiapptec.com/sitemap_index.xml)